Back
Verified active · 12h ago

Director, Commercial Manufacturing

Orca BioOrca Bio·Biotechnology

Compensation

$175k - $210k/per-year-salary

Apply effort

~6 min

Lever

Posted

68 days

01

About the role

More than one million people in the United States today are fighting blood cancer. While a traditional allogeneic stem cell transplant has been the best hope for many, the transplant itself can prove fatal or lead to serious conditions, such as graft vs. host disease. Orca Bio is a late-stage biotechnology company redefining the transplant process by developing next-generation cell therapies with the goal of providing significantly better survival rates with dramatically fewer risks. With our purified, high-precision investigational cell therapies we hope to not only replace patients' blood and immune systems with healthy ones, but also restore their lives.
We have built a state-of-the-art, 100,000-square-foot manufacturing facility in Sacramento, CA (7910 Metro Air Pkwy) to ensure the consistent and reliable delivery of our high-precision cell therapy products. This site is essential to advancing our clinical pipeline and supporting future commercial availability of our life-saving therapies.

The Director, Commercial Manufacturing is responsible for leadership of cell therapy manufacturing operations and production support functions to ensure reliable, compliant, and timely delivery of patient-specific therapies. This role drives consistent batch execution, operational discipline, and cross-functional alignment to meet on-time patient delivery while maintaining the highest standards of quality and safety.

The Director will build and sustain robust production systems, embed lean manufacturing principles, and lead continuous improvement initiatives to scale operations in a dynamic, GMP-regulated environment.

Skills & Tags

02

Aplyr's read

Orca Bio pioneers advanced cell therapies for cancer, attracting professionals in biotechnology, quality control, and manufacturing operations.

Synthesized from recent postings & public sources

What's promising

  • Orca Bio's proprietary platform offers innovative, targeted therapies for cancer treatment.
  • Recent expansion in roles indicates company growth and diversification.
  • Focus on advanced cell therapies positions Orca Bio at the forefront of biotechnology innovation.

What to watch

  • High specialization may limit opportunities for those outside biotechnology or life sciences.
  • The niche market focus can present financial volatility risks.
  • Demanding shift work, including nights and weekends, may affect work-life balance.

Why Orca Bio

  • Orca Bio's proprietary cell therapy platform sets it apart in the biotech industry.
  • The company's focus on both cancer and other diseases broadens its therapeutic impact.
  • Strong emphasis on quality control and manufacturing excellence ensures high product standards.

Aplyr’s read is generated by AI from public sources. Was it useful?

03

About Orca Bio

Orca Bio is a biotechnology company focused on developing advanced cell therapies for cancer and other diseases, utilizing its proprietary platform to create targeted therapies.

04

Similar roles